Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The study will assess the clinical efficacy at Day 14-21 (Test of Cure), 14-21 days after
starting the study drug; those subjects from whom a baseline pathogen is identified will also
be assessed for bacteriologic response. All subjects who receive 1 dose of study medication
will be assessed for safety.